Profile picture

Associate Professor Yaroslav Lutay

NSC Strazhesko Institute of Cardiology and Clinical Medicine, Kiev (Ukraine)
Membership: ESC Professional Member ACVC Member
Follow
Logo ESC

Contributor content

No-reflow, acute heart failure and ventricular fibrillation are more common in STEMI patients in wartime conditions.
Presentation
No-reflow, acute heart failure and ventricular fibrillation are more common in STEMI patients in wartime conditions.
Early intensive lipid-lowering therapy prevents development of no-reflow phenomenon and reduces the incidence of post MI LV remodeling
Presentation
Early intensive lipid-lowering therapy prevents development of no-reflow phenomenon and reduces the incidence of post MI LV remodeling
Positive effects of intravenous 5-lipoxygenase inhibitor quercetin in acute ST elevation myocardial infarction: intermediate results of ongoing randomized open blinded multicenter study
Presentation
Positive effects of intravenous 5-lipoxygenase inhibitor quercetin in acute ST elevation myocardial infarction: intermediate results of ongoing randomized open blinded multicenter study
Low dose ezetimibe / atorvastatin combination in acute ST elevation myocardial infarction
Presentation
Low dose ezetimibe / atorvastatin combination in acute ST elevation myocardial infarction
Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.
Presentation
Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.
Effects of intravenous 5-lipoxygenase inhibitor quercetin on endothelial function, systemic inflammation and oxidative stress in acute ST elevation myocardial infarction.
Presentation
Effects of intravenous 5-lipoxygenase inhibitor quercetin on endothelial function, systemic inflammation and oxidative stress in acute ST elevation myocardial infarction.
Myeloperoxidase concentration is associated with endothelial dysfunction and can be decreased by lipoxygenase inhibitor Quercetin in acute phase of STEMI.
Presentation
Myeloperoxidase concentration is associated with endothelial dysfunction and can be decreased by lipoxygenase inhibitor Quercetin in acute phase of STEMI.

ESC 365 is supported by